Synthesis and Anti-cancer Activities of Apigenin Derivatives

ISSN: 1875-6638 (Online)
ISSN: 1573-4064 (Print)

Volume 13, 8 Issues, 2017

Download PDF Flyer

Medicinal Chemistry

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Honorary Life Fellow
Kings College
University of Cambridge

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 1.458
5 - Year: 1.423

Synthesis and Anti-cancer Activities of Apigenin Derivatives

Medicinal Chemistry, 10(7): 747-752.

Author(s): Xing Zheng, Liuying Yu, Jing Yang, Xu Yao, Wenna Yan, Shaowei Bo, Ya Liu, Yun Wei, Zhiyi Wu and Guan Wang.

Affiliation: Institute of Pharmacy & Pharmacology, University of South China, Hengyang, 421001, China.


A novel series of apigenin derivatives with phloroglucinol or resorcinol as raw materials were synthesized according to Baker-Venaktaraman reaction and their in vitro inhibitory activities on colorectal adenocarcinoma (HT-29) and leucocythemia (HL-60) cell lines were evaluated by the standard methyl thiazole tetrazolium (MTT) method. The results of biological test showed that some of apigenin derivatives possessed stronger anti-cancer activities than apigenin. Compound 6 showed the strongest activity against colorectal adenocarcinoma (HT-29) and leucocythemia (HL-60) cell lines with IC50 valure of 2.03±0.22 µ M, 2.25±0.42 µ M, it was better than 5-FU (12.92±0.61 µ M, 9.56±0.16 µ M), which shows a potential compound for colorectal adenocarcinoma and leucocythemia.


Anti-cancer activities, apigenin, baker-venkataraman reaction, flavonoids, MTT method, SAR.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 10
Issue Number: 7
First Page: 747
Last Page: 752
Page Count: 6
DOI: 10.2174/1573406410666140307152557
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science